Health
SFRP2 and PD-1 immunotherapy combination halts osteosarcoma metastasis in model – EurekAlert
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
IMAGE: Hollings Cancer Center researcher Nancy Klauber-DeMore, M.D., is leading the first breakthrough in pediatric osteosarcoma treatment in decades.
view more
Credit: MUSC Hollings Cancer Center/Marquel Coaxum
In a cancer that has not seen new targeted…
Continue Reading
-
Business17 hours agoTop brokers name 3 ASX shares to buy next week 25 May 2025
-
Noosa News12 hours agoFears for the future of retro Chinese dining after blaze guts Sundoo in Townsville
-
General14 hours agoAustralia’s native flora emerges as an increasingly popular muse for bonsai hobbyists
-
Noosa News17 hours agoOn your marks, get set, buy!